Reflation, reopenings and a packed data docket Reflation, reopenings and a packed data docket Reflation, reopenings and a packed data docket

Reflation, reopenings and a packed data docket

Equities 6 minutes to read

Summary:  US futures trade directionless oscillating between gains and losses, while rebounding Chinese stocks lead the charge in Asia, breaking from their recent underperformance. An air of quiet positivity lingers as we await further catalysts.

Global equities are kicking off the month of April and new quarter in the green. Following on from what was a solid Q1 performance, the S&P 500 continues to hit fresh all-time highs, with last week being the 3rd straight weekly gain for the broad index and the index already putting in 6 all-time closing highs 13 days into April. This as financial conditions remain accommodative, front month VIX continues to collapse and the dollar resumes its decline. All told, reflation remains in play, the good news continues to roll in for growth and companies continue to participate in the economic recovery.

Yesterday’s US CPI read provided fuel for the debate over the trajectory of inflation in the coming months, of particular interest for the path of longer duration bond yields and path currently outlined by the Fed deeming inflationary pressures transitory.

Inflation data did surprise to the upside, but the surprise was benign print relative to what had been feared, so sufficiently priced in US Treasuries. There is no guarantee that this pattern will continue over the coming months, one month does not a trend make. We are only just entering the period where we will see higher inflation prints as the “base effect cliff” comes firmly into play. As supply constraints, pent up demand and fiscally juiced up consumers collide with the base effects cliff it is logical to expect higher inflation is coming and that long-end yields will trade higher in the coming months.

Recent PMI, small business surveys and PPI data all point to inflationary pressures with supply bottlenecks and increasing input costs flowing through to pricing intentions. In addition, commodity prices continue to push higher showing strong read through to PPI prints.

The risks going forward for assets are squarely focussed on the winding back of extremely loose monetary or fiscal policy (looking at you, NZX 50/SH COMP), inflation, taper tantrums and regulations/taxes – None of which are in plain sight yet. This will change as we head into 2H21, but with a big rate of change acceleration in both growth and inflation data keeping long-dated US yields likely headed higher – it seems premature to ditch reflation trades.

Up next is 1Q earnings with US banks kicking off the season. The banks have been a key beneficiary of the reflation trade. Benefitting from a reaccelerating economy, higher yields, vaccine rollout and a robust fiscal pulse. Post a period of underperformance for these cyclical reflation trade beneficiaries’ earnings could be an important catalyst for renewed confidence in reopening and cyclicality trades.

In general, with the spotlight on inflation, investors will be on the lookout for incoming margin pressures or any hit to earnings from higher input costs. But the broader thematic will be all about whether the COVID winners can beat their tough comps and whether earnings will be a continued catalyst for reopening/reflation trades.

US retail sales will also be in the spotlight as investors parse the impact of the vaccine rollout, an ongoing recovery in the labour market and March stimulus cheques on consumption. UK retail sales also coming in strong earlier this week vs. the 2020 COVID cliff but also the 2019 comparison as the vaccine rollout continues to outperform, providing a catalyst for the value heavy FTSE 100 index as anticipations of a booming NH Summer spending rebound in conjunction with the reopening are firmed.

Tomorrow locally jobs data should confirm a continued recovery in the labour market, but we may start to see the pace of gains moderate with JKP winding up. Leading indicators have bounced from strength to strength, the employment sub index in the AI Group PMI hit a record high of 66.0. AND the ABS Job Vacancies Survey also hit a record high of 288.7k. with employment growth outpacing the uptick in participation keeping downward pressure on headline unemployment.

In general, the data continue to outline an accelerating rebound in the domestic recovery. The NAB business conditions survey is sitting at record highs, whilst consumer sentiment has ramped to an 11-year high. A continued pick up in hiring and investment providing plenty of momentum for the ongoing recovery even as fiscal support measures wind off and continuing to support the ongoing recovery in labour market. This pickup in growth, alongside recovery in business conditions and confidence as activity normalises is one of the pillars of support for ongoing earnings recoveries and sustained gains for reflation trades. Confirming reflationary positioning and leverage to economic sensitivity e.g., cyclicals, commodities, materials, industrials, financials, energy, small caps, international stocks (ex-US) etc.


The Saxo Group entities each provide execution-only service and access to Analysis permitting a person to view and/or use content available on or via the website is not intended to and does not change or expand on this. Such access and use are at all times subject to (i) The Terms of Use; (ii) Full Disclaimer; (iii) The Risk Warning; (iv) the Rules of Engagement and (v) Notices applying to Saxo News & Research and/or its content in addition (where relevant) to the terms governing the use of hyperlinks on the website of a member of the Saxo Group by which access to Saxo News & Research is gained. Such content is therefore provided as no more than information. In particular no advice is intended to be provided or to be relied on as provided nor endorsed by any Saxo Group entity; nor is it to be construed as solicitation or an incentive provided to subscribe for or sell or purchase any financial instrument. All trading or investments you make must be pursuant to your own unprompted and informed self-directed decision. As such no Saxo Group entity will have or be liable for any losses that you may sustain as a result of any investment decision made in reliance on information which is available on Saxo News & Research or as a result of the use of the Saxo News & Research. Orders given and trades effected are deemed intended to be given or effected for the account of the customer with the Saxo Group entity operating in the jurisdiction in which the customer resides and/or with whom the customer opened and maintains his/her trading account. Saxo News & Research does not contain (and should not be construed as containing) financial, investment, tax or trading advice or advice of any sort offered, recommended or endorsed by Saxo Group and should not be construed as a record of our trading prices, or as an offer, incentive or solicitation for the subscription, sale or purchase in any financial instrument. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, would be considered as a marketing communication under relevant laws.

Please read our disclaimers:
- Notification on Non-Independent Investment Research (
- Full disclaimer (

None of the information contained here constitutes an offer to purchase or sell a financial instrument, or to make any investments. Saxo does not take into account your personal investment objectives or financial situation and makes no representation and assumes no liability as to the accuracy or completeness of the information nor for any loss arising from any investment made in reliance of this presentation. Any opinions made are subject to change and may be personal to the author. These may not necessarily reflect the opinion of Saxo or its affiliates.

Saxo Capital Markets HK Limited
19th Floor
Shanghai Commercial Bank Tower
12 Queen’s Road Central
Hong Kong

Contact Saxo

Select region

Hong Kong S.A.R
Hong Kong S.A.R

Saxo Capital Markets HK Limited (“Saxo”) is a company authorised and regulated by the Securities and Futures Commission of Hong Kong. Saxo holds a Type 1 Regulated Activity (Dealing in Securities); Type 2 Regulated Activity (Dealing in Futures Contract); Type 3 Regulated Activity (Leveraged Foreign Exchange Trading); Type 4 Regulated Activity (Advising on Securities) and Type 9 Regulated Activity (Asset Management) licenses (CE No. AVD061). Registered address: 19th Floor, Shanghai Commercial Bank Tower, 12 Queen’s Road Central, Hong Kong.

Trading in financial instruments carries various risks, and is not suitable for all investors. Please seek expert advice, and always ensure that you fully understand these risks before trading. Trading in leveraged products may result in your losses exceeding your initial deposits. Saxo does not provide financial advice, any information available on this website is ‘general’ in nature and for informational purposes only. Saxo does not take into account an individual’s needs, objectives or financial situation. Please click here to view the relevant risk disclosure statements.

The Saxo trading platform has received numerous awards and recognition. For details of these awards and information on awards visit

The information or the products and services referred to on this site may be accessed worldwide, however is only intended for distribution to and use by recipients located in countries where such use does not constitute a violation of applicable legislation or regulations. Products and services offered on this website are not directed at, or intended for distribution to or use by, any person or entity residing in the United States and Japan. Please click here to view our full disclaimer.

Apple, iPad and iPhone are trademarks of Apple Inc., registered in the US and other countries. AppStore is a service mark of Apple Inc. Android is a trademark of Google Inc.